Skip to main navigation Skip to search Skip to main content

Risk of cardiovascular disease and cancer in patients initiating JAK versus IL-4/-13 inhibitors for atopic dermatitis

  • Sizheng Zhao*
  • , Gema Hernandez
  • , Uazman Alam
  • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
JournalInternational Journal of Dermatology
DOIs
Publication statusPublished - 28 Apr 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • eczema
  • cardiovascular disease
  • malignancy
  • tofacitinib
  • upadacitinib
  • dupilumab

Cite this